Nautilus Biotechnology, Inc.NAUTNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank57
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-4.17
↑ 39% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-6.88
Historical baseline
PeriodValueYoY Change
2025-4.17-40.2%
2024-2.98+49.2%
2023-5.87-51.5%
2022-3.87+55.5%
2021-8.70+62.1%
2020-22.97-248.9%
2019-6.58-5597.9%
20180.12-